59 related articles for article (PubMed ID: 9202313)
21. Distinctive sphingolipid patterns in chronic multiple sclerosis lesions.
Podbielska M; Szulc ZM; Ariga T; Pokryszko-Dragan A; Fortuna W; Bilinska M; Podemski R; Jaskiewicz E; Kurowska E; Yu RK; Hogan EL
J Lipid Res; 2020 Nov; 61(11):1464-1479. PubMed ID: 32769146
[TBL] [Abstract][Full Text] [Related]
22. The role of B cells in multiple sclerosis: Current and future therapies.
Negron A; Robinson RR; Stüve O; Forsthuber TG
Cell Immunol; 2019 May; 339():10-23. PubMed ID: 31130183
[TBL] [Abstract][Full Text] [Related]
23. Effect of Fasudil on remyelination following cuprizone-induced demyelination.
Wang J; Sui RX; Miao Q; Wang Q; Song LJ; Yu JZ; Li YH; Xiao BG; Ma CG
CNS Neurosci Ther; 2020 Jan; 26(1):76-89. PubMed ID: 31124292
[TBL] [Abstract][Full Text] [Related]
24. The role of glial-neuronal metabolic cooperation in modulating progression of multiple sclerosis and neuropathic pain.
Robinson RR; Dietz AK; Maroof AM; Asmis R; Forsthuber TG
Immunotherapy; 2019 Feb; 11(2):129-147. PubMed ID: 30730270
[TBL] [Abstract][Full Text] [Related]
25. Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.
Peschl P; Bradl M; Höftberger R; Berger T; Reindl M
Front Immunol; 2017; 8():529. PubMed ID: 28533781
[TBL] [Abstract][Full Text] [Related]
26. Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis.
Wang CK; Gruber CW; Cemazar M; Siatskas C; Tagore P; Payne N; Sun G; Wang S; Bernard CC; Craik DJ
ACS Chem Biol; 2014 Jan; 9(1):156-63. PubMed ID: 24147816
[TBL] [Abstract][Full Text] [Related]
27. The immunomodulatory and neuroprotective effects of mesenchymal stem cells (MSCs) in experimental autoimmune encephalomyelitis (EAE): a model of multiple sclerosis (MS).
Al Jumah MA; Abumaree MH
Int J Mol Sci; 2012; 13(7):9298-9331. PubMed ID: 22942767
[TBL] [Abstract][Full Text] [Related]
28. Sphingolipids in multiple sclerosis.
Jana A; Pahan K
Neuromolecular Med; 2010 Dec; 12(4):351-61. PubMed ID: 20607622
[TBL] [Abstract][Full Text] [Related]
29. Diminished degradation of myelin basic protein by anti-sulfatide antibody and interferon-gamma in myelin from glia maturation factor-deficient mice.
Menon K; Wu Y; Haas J; Sahu SK; Yang B; Zaheer A
Neurosci Res; 2007 Jun; 58(2):156-63. PubMed ID: 17383764
[TBL] [Abstract][Full Text] [Related]
30. Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology.
Marta CB; Taylor CM; Coetzee T; Kim T; Winkler S; Bansal R; Pfeiffer SE
J Neurosci; 2003 Jul; 23(13):5461-71. PubMed ID: 12843245
[TBL] [Abstract][Full Text] [Related]
31. Cross-reactivity of anti-galactocerebroside autoantibodies with a Trypanosoma brucei proteolipidic epitope.
Girard M; Bisser S; Buscher P; Bouteille B; Preud'homme JL; Jauberteau MO
Clin Exp Immunol; 2000 Mar; 119(3):516-22. PubMed ID: 10691925
[TBL] [Abstract][Full Text] [Related]
32. Demyelination in brain cell aggregate cultures, induced by a monoclonal antibody against the myelin/oligodendrocyte glycoprotein (MOG).
Honegger P; Matthieu JM; Lassmann H
Schweiz Arch Neurol Psychiatr (1985); 1989; 140(1):10-3. PubMed ID: 2467359
[TBL] [Abstract][Full Text] [Related]
33. Novel oligodendrocyte transmembrane signaling systems. Investigations utilizing antibodies as ligands.
Dyer CA
Mol Neurobiol; 1993; 7(1):1-22. PubMed ID: 8391270
[TBL] [Abstract][Full Text] [Related]
34. CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies.
Wajgt A; Górny M
Acta Neurol Scand; 1983 Nov; 68(5):337-43. PubMed ID: 6198864
[TBL] [Abstract][Full Text] [Related]
35. Demyelinating antibodies to myelin oligodendrocyte glycoprotein and galactocerebroside induce degradation of myelin basic protein in isolated human myelin.
Menon KK; Piddlesden SJ; Bernard CC
J Neurochem; 1997 Jul; 69(1):214-22. PubMed ID: 9202313
[TBL] [Abstract][Full Text] [Related]
36. Demyelination induced in aggregating brain cell cultures by a monoclonal antibody against myelin/oligodendrocyte glycoprotein.
Kerlero de Rosbo N; Honegger P; Lassmann H; Matthieu JM
J Neurochem; 1990 Aug; 55(2):583-7. PubMed ID: 1695240
[TBL] [Abstract][Full Text] [Related]
37. Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice.
Morris-Downes MM; Smith PA; Rundle JL; Piddlesden SJ; Baker D; Pham-Dinh D; Heijmans N; Amor S
J Neuroimmunol; 2002 Apr; 125(1-2):114-24. PubMed ID: 11960647
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
